An eight-month clinical study of LA-2575 30.0 mg: a new 4-month, subcutaneous delivery system for leuprolide acetate in the treatment of prostate cancer (Q44534045)
Jump to navigation
Jump to search
scientific article published in August 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An eight-month clinical study of LA-2575 30.0 mg: a new 4-month, subcutaneous delivery system for leuprolide acetate in the treatment of prostate cancer |
scientific article published in August 2003 |
Statements
1 reference
An eight-month clinical study of LA-2575 30.0 mg: a new 4-month, subcutaneous delivery system for leuprolide acetate in the treatment of prostate cancer (English)
1 reference
Oliver Sartor
1 reference
Martin K Dineen
1 reference
Ramon Perez-Marreno
1 reference
Franklin M Chu
1 reference
Graham J Carron
1 reference
Robert C Tyler
1 reference
1 August 2003
1 reference
1 reference
62
1 reference
2
1 reference
319-323
1 reference
Identifiers
1 reference
1 reference